Cullinan Oncology Inc
NASDAQ:CGEM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cullinan Oncology Inc
NASDAQ:CGEM
|
US |
|
PEH Wertpapier AG
F:PEH
|
DE |
|
L
|
Liberty Global PLC
NASDAQ:LBTYB
|
UK |
|
Kukdo Chemical Co Ltd
KRX:007690
|
KR |
|
F
|
Fon SE
WSE:FON
|
EE |
|
M
|
Mitsubishi Estate Co Ltd
XMUN:MES
|
JP |
|
Range International Ltd
ASX:RAN
|
AU |
|
Wincanton PLC
F:5K2
|
UK |
|
L
|
LTC Co Ltd (Hwaseong)
KOSDAQ:170920
|
KR |
|
Vianet Group PLC
LSE:VNET
|
UK |
|
M
|
MSCI Inc
XBER:3HM
|
US |
|
8
|
8VI Holdings Ltd
ASX:8VI
|
SG |
|
I
|
IBI Investment House Ltd
TASE:IBI
|
IL |
|
K
|
Koryo Credit Information Co Ltd
KOSDAQ:049720
|
KR |
|
K
|
KSE Ltd
BSE:519421
|
IN |
|
DIAMOND FOOD INDONESIA Tbk PT
IDX:DMND
|
ID |
Bankruptcy Probability
Cullinan Oncology Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cullinan Oncology Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Cullinan Oncology Inc
NASDAQ:CGEM
|
1.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
211.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
180.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
81.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cullinan Oncology Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cullinan Oncology Inc has no debt.
You can find a full breakdown on its Balance Sheet.
